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Abstract:This review focuses specifically on the developments in brain imaging,
as opposed to the spine, and specifically conventional, clinical, cross-sectional
imaging, looking primarily at advances in magnetic resonance imaging (MRI)
and computed tomography (CT). These fields are viewed from a perspective of
landmark publications in the last 50 years and subsequently more in depth using
sentinel publications from the last 5 years. It is also written from a personal per-
spective, with the authors havingwitnessed the evolution of both fields from their
initial clinical introduction to their current state. Both CTandMRI have made tre-
mendous advances during this time, regarding not only sensitivity and spatial res-
olution, but also in terms of the speed of image acquisition. Advances in CT in
recent years have focused in part on reduced radiation dose, an important topic
for the years to come. Magnetic resonance imaging has seen the development
of a plethora of scan techniques, with marked superiority to CT in terms of tissue
contrast due to the many parameters that can be assessed, and their intrinsic sen-
sitivity. Future advances inMRI for clinical practicewill likely focus both on new
acquisition techniques that offer advances in speed and resolution, for example,
simultaneous multislice imaging and data sparsity, and on standardization and
further automation of image acquisition and analysis. Functional imaging tech-
niques including specifically perfusion and functional magnetic resonance imag-
ing will be further integrated into the workflow to provide pathophysiologic
information that influence differential diagnosis, assist treatment decision and
planning, and identify and follow treatment-related changes.
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(Invest Radiol 2015;00: 00–00)
S tudies published in Investigative Radiology that have received thehighest number of citations (specifically the top 250) include a di-
verse but critical set of advances for our field. In this section, 10 impor-
tant central nervous system (CNS) studies are highlighted. The number
4 most cited study quantitates the relaxation properties of the commer-
cially available gadolinium chelates at the clinically relevant field
strengths used today, 1.5 and 3 T.1 This article also serves as the refer-
ence standard in the field, although it is likely to be displaced with time
by a more recent publication in the journal, which expands the compar-
ison to include 1.5, 3, and 7 T, and specifically compares the agents in
the most relevant environment, that of human blood.2 One focus of the
journal historically has been contrast media, and the appearance of an
additional study in the top 50 is not surprising. The number 21 on this
list is the first demonstration of significant differences in relaxivity be-
tween extracellular gadolinium chelates, depending upon their design.
This is a potentially important differentiator between agents, with impli-
cations in routine clinical use.3 The 31st most cited study introduces the
topic of mean transit time in computed tomography (CT), launching the
field of cerebral perfusion for cross-sectional imaging,4 which is now a
widely used clinical measure for both CT and magnetic resonance im-
aging (MRI). Evaluation of cerebral ischemia and neoplastic disease to-
day incorporates measurement of cerebral blood volume, in the first
disease category for prognosis and therapeutic decision making and in
the second for differential diagnosis. Also in the top 250 cited articles
is the first description of diffusion-weighted imaging (DWI),5 and its
potential as an important additional noninvasive MR marker. The im-
portance of diffusion imaging lies only just behind the fundamental pa-
rameters of T1 and T2, and once available was rapidly integrated into
clinical routine. Additional critical advances in CT that are highlighted
by articles in the top 250 cited studies include the first description of
sagittal and coronal reformatted images obtained from axial scanning6
and the first description of stereotactic head frame use.7 Both techniques
are now routinely used and today represent standard clinical practice. In
MRI, additional important advances highlighted by articles include the
first demonstration of brain mapping (functional magnetic resonance im-
aging), which was shown for the visual cortex,8 the advent, challenges,
and advantages of 3 T for brain imaging,9 and the description of an
early important contraindication for MR, the presence of a deep brain
stimulator.10 Another landmark article in the top 250 articles published
concerns health policy, specifically the evaluation of research methods/
publication by disease, level of impact, and quality of research.11
The past 5 years of publications in Investigative Radiology were
evaluated in greater detail, looking for trends as well as important focus
areas. Forty references from this period are highlighted, and they estab-
lish the most important areas of CNS research for the next decade, as well
as the disease entities of greatest focus (cerebral ischemia and CNS neo-
plasia). Regarding cerebral ischemia, the focus in the radiologic literature
is predominantly on improved imaging technique. Computed tomogra-
phy has developed to the extent that whole-brain perfusion is now pos-
sible, being previously limited to only a few slices.12 This of itself is a
critical advance but just as important is the acquisition of such datawith
markedly lower radiation dose (Fig. 1). Widespread availability of CT
perfusion today makes triage of patients presenting with clinical symp-
toms of ischemia possible, which is of critical importance relative to
therapy. The availability of CT perfusion also has had other benefits,
for example, improving detection of smaller ischemic lesions.13 Auto-
mated CT techniques, based on image processing alone or on the char-
acterization of tissue using dual-energy CT, will eventually be a part of
mainstream clinical practice, improving lesion detection and character-
ization. Automatic detection and volume estimation of infarcts, in par-
ticular acute infarcts that are quite subtle on CT, is well within the grasp
today of computer technology.14 In another example, the limited ability
to differentiate between hemorrhage and calcification within lesions
still detracts from the clinical value of CT, with dual energy offering a
major advance in this role.15 Color-coded CT angiography, a new
method of displaying dynamic cerebral CT angiography, provides the
individual interpreting the exam with important additional diagnostic
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information, including specifically differentiation between antegrade
and retrograde flow and leptomeningeal collateralization (Fig. 2).16
Similar color-coding is being applied in MRI, for applications such as
the supply and drainage of arteriovenous malformations and for collat-
eral flow in cerebrovascular disease. More fundamental research is be-
ing conducted both in animal models and in patients, which will expand
our understanding of ischemia17,18 and lead possibly to innovative ther-
apies.19 Carotid vessel wall imaging,20,21 and improved evaluation of
flow within the carotid artery,22 may add as well to our ability to evaluate
patients, their risk, and the severity of the disease present.
Research focused on neoplastic disease spans the range from
animal models of disease to computer postprocessing techniques for im-
proved diagnosis. Metastatic disease is, within the more general category
of neoplasia, a major area of research both due to its clinical importance
(and frequency) and its amenability to improved diagnosis. Much can be
done with MRI techniques to further improve lesion detectability. The
best acquisition techniques are still being identified and refined.23–25
Computer-aided image evaluation will likely be a mainstay of diagnostic
reporting, although currently in its infancy.26 Computed tomography
techniques also continue to evolve, particularly the use of dual energy,
with substantial possibilities for improved lesion delineation and image
quality, particularly in soft tissue.27 Treatment monitoring is a further
area for which MRI plays a critical role, with more extensive clinical
evaluation and definition of the most important parameters needed.28
A challenging area that remains is the failure of MRI contrast enhance-
ment to detect all metastatic lesions within the brain.29 Chemistry is far
advanced in comparison to 30 years ago when the gadolinium chelates
were first developed. Lesion detectability andmany other clinically im-
portant parameters could markedly benefit if research within industry
continues, specifically development of the next generation of intrave-
nous MRI contrast media, with a substantial improvement in relaxivity.
Unfortunately, the cost of such development due to regulatory issues
has spiraled beyond control, dimming such prospects.30
Further developments in MRI technique, both acquisition and
postprocessing, should have major impact upon utilization of this
modality over the next decade. Innovative studies in Investigative Radi-
ology illustrate the current advances being made in MR angiography
(MRA),31 quantification of perfusion and permeability,32 detection
and quantification of iron,33 further image acquisition techniques for
improved lesion detectability and quantification,34 and new functional
evaluations, with mainstream application for large clinical subpopula-
tions.35 The likely focus of MR development in the next decade will
be in image reconstruction and postprocessing, rather than new acquisi-
tion sequences with different tissue contrast, and specifically involving
the field of data sparsity.36 For conventional imaging, this approach has
the potential for a 2-fold to 4-fold increase in scan speed, whereas in dy-
namic techniques such as MR angiography, the potential is on the order
of more than 10-fold.
The field of 7 T is very much in its infancy in terms of routine
clinical use in the brain. Future clinical scanners might not be 7 T per
se but simply substantially higher in field strength than the premier clin-
ical 3 TMR systems of today. It is also possible that such ultrahigh field
scanners might develop a niche for clinical imaging in the high-end pri-
vate world (with direct fee for service), which has the financial re-
sources to purchase and maintain such systems, and which is also not
dependent uponmedical insurance plans and reimbursement. Advances
are ongoing in brain imaging, with clinical studies based on scanner and
sequence acquisition advances demonstrating the potential for brain im-
aging at an intrinsic resolution and with tissue contrasts not possible at
3 T (Fig. 3).37–40 As with other specific techniques such as susceptibil-
ity weighted imaging,39 time of flight magnetic resonance angiography
at ultrahigh field should be markedly superior to that at 3 T. Advances
in TOF imaging technique are ongoing, with amelioration of SAR con-
straints enabling venous suppression,41 improving excitation fidelity,
leading to higher contrast, and achieving smooth slab transitions.42
Carotid imaging at 7 T has attracted substantial attention, given the
importance of spatial resolution in evaluating the carotid wall and athero-
sclerotic disease.43–45 Other specialty areas within the CNS where ultra-
high field MR could easily surpass 3 T in terms of diagnostic efficacy
include the orbit,46 sella, and internal auditory canal. These are all areas
where signal-to-noise ratio (SNR), contrast-to-noise ratio, and spatial res-
olution are critical for diagnosis. Although imaging of other nuclei has
yet to have a clinical impact (despite early predictions, which were made
even for imaging at 1.5 T), ultrahigh field MR offers greater potential in
this area. Early imaging results for sodium in the evaluation of astrocyto-
mas reveal its value for differentiation on the basis of tumor grade, aswell
as providing additional lesion characterization.47
Magnetic resonance-positron emission tomography (PET) re-
sembles in its development the field of MR itself. Its introduction was
FIGURE 1. Whole-brain CT perfusion, now clinically available due to
technologic innovations, improves diagnostic utility andmakes possible
the detection of small acute brain infarcts. The CT scans in this patient,
specifically the cerebral blood flow and mean transit time images, were
acquired 1.5 hours after symptom onset and reveal a small ischemic
lesion in the left central semiovale. The lesion was confirmed by MRI
(DWI), which was performed 2 days later. Reprinted with permission
from Thierfelder et al.13 Figure 1 can be viewed online in color at
www.investigativeradiology.com.
FIGURE 2. Color-coded CT angiography, a recent innovation with
applicability in acute infarction, is shown in a patient with an occlusion of
the right internal carotid artery. At the 2 levels presented, there is delayed flow
within the right middle cerebral artery (MCA) vessels, with collateralization
via the anterior communicating artery to theMCA. From the CT perfusion
study, cerebral blood flow is markedly reduced as well in the right MCA
territory. Reprinted with permission from Thierfelder et al.16 Figure 2 can
be viewed online in color at www.investigativeradiology.com.
FIGURE 3. Seven tesla offers unparalleled spatial resolution in imaging of
the brain, opening new opportunities both for the study of normal
anatomy and disease. In the example presented, 7 T offers detailed
visualization of the perivascular spaces in the basal ganglia in an elderly
woman, which is of potential utility in the study of these fluid-filled cavities
in aging and small vessel disease. Note also the prominent generalized
dilatation of the perivascular spaces. T1-weighted and 3-dimensional (3D)
time of flight magnetic resonance angiography images are presented.
Reprinted with permission from Bouvy et al.37
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marked by very high costs and long exam times, with acceptance lim-
ited as well by the existence of a prior well-validated competitor,
PET-CT (the competitor for MR upon its introduction was CT itself ).
MR-PET offers many advantages, such as true simultaneity of acquisi-
tion, the possibility of diffusion tensor imaging,48 and metabolic map-
ping with spectroscopy.49 Validation studies with the first commercial
units show excellent quantification and stability,50 with more than 50
units in place worldwide as of 2015.
Substantial advances have also occurred in CT brain imaging in
the last 5 years, with the latest scanner and software design providing
multiple mechanisms to lower radiation dose.51 Of importance for brain
is the use of lower kV (≤80), offering both lower radiation dose and
higher sensitivity to iodinated contrast media. This is particularly im-
portant for CT angiography.52,53
Not to be overlooked in this assessment, however, is the marked
improvement in image quality and imaging technology over the past
decades (Fig. 4). This is for all modalities, including MR, CT, and dig-
ital subtraction angiography. For example, the latter (flat panel CT) can
now provide excellent cross-sectional images, with soft tissue contrast
approaching that of dedicated CT units. Overall image quality has ad-
vanced to a remarkable extent, in particular forMR, with scan times de-
creasing by factors of 10 to 100 since the early 1980s. In regard to
intravenous contrast media for CT (and digital subtraction angiogra-
phy), the nonionic iodinated contrast media have now replaced their
ionic counterparts. In addition, 1988 marked the clinical launch of the
gadolinium chelates for MR as intravenous contrast media. In the latter
field, there has been a recent trend toward use only of the macrocyclic
agents because of their superior safety profile. The gadolinium chelates
are critical to diagnostic MRI of the CNS, with more than 300 million
total administrations to date worldwide, and approximately 30 million
FIGURE 4. State of the art in 1984, a patient with multiple
sclerosis (A). The images were acquired at 0.5 T, with a voxel size of
10  2.2  2.2 mm3. Both images were acquired using 3D spin echo
technique, with scan times respectively of 47 and 37 minutes. The
left-hand image is T1-weighted, an inversion recovery technique, and the
right-hand image is T2-weighted, however, with repetition time = 1000
milliseconds. This is compared to state-of-the-art images in 2015 (B), also
in a patient with multiple sclerosis, imaged at 3 T. DIR indicates double
inversion recovery. In-plane resolution was submillimeter, with slice
thicknesses of 1 to 4mmdependent upon technique and scan times on
the order of 5 minutes or less for each imaging sequence. Reprinted with
permission from Runge et al (AJR Am J Roentgenol.
1984;143:1015–1026) and Runge et al (Neuroradiology: The Essentials
with MR and CT. New York, NY: Thieme Medical Publishers; 2015).
FIGURE 5. The efficacy of a gadolinium chelate for improving lesion
detection and differential diagnosis in the brainwas first shown in 1984,
using a dog brain abscess model. This work received the Dyke award that
year from the American Society of Neuroradiology. A coronal
postcontrast T1-weighted image at 0.5 T is presented from that research
(A), togetherwith thematching enhanced coronal CT, both depicting a
large ring-enhancing lesion. Today, intravenous contrast administration is
broadly applied for brain imaging inMRwithwidespread utility. Images
obtained at 3 T in a patient with metastatic melanoma are presented,
both precontrast and postcontrast. Although several small lesions are
visualized in the frontal lobes, precontrast (likely due to hemorrhage), the
devastating extent of disease in this patient is only evident postcontrast.
Reprinted with permission from Runge et al (AJNR Am J Neuroradiol.
1985;6:139–147) and Runge et al (Neuroradiology: The Essentials with
MR and CT. New York, NY: Thieme Medical Publishers; 2015).
FIGURE 6. MRI at 3 T of a small cortical acute infarct (arrow) illustrating
simultaneous multislice accelerated diffusion-weighted echo planar
imaging. The advent of this technique is analogous to that of multislice
2-dimensional imaging in the 1980s, and as such may represent one of
the major image acquisition innovations in the current decade with
widespread clinical applicability. Using an acceleration factor of 3 in
combination with a reduction in slice thickness, 2-mm sections through
the entire brain can be acquired in a reasonable scan time, with image
quality (and SNR) comparable to the 4-mm standard diffusion-weighted
EPI acquisition. Because of the thicker section (4mm), this small cortical
infarct was not seen on the conventional readout segmented DWI
acquisition (readout segmentation of long echo-trains) or on the
accelerated 2-band scan but was noted on one of the two 2-mm sections
acquired at this level, an advance made possible by the use of slice
acceleration and in this instance 3 bands.
Investigative Radiology • Volume 00, Number 00, Month 2015 MRI and CT of the Brain—50 Years of Innovation
© 2015 Wolters Kluwer Health, Inc. All rights reserved. www.investigativeradiology.com 3
Copyright © 2015 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
enhanced MR procedures per year. Half of these are for CNS imaging,
where the gadolinium chelates play a critical role for both disease detec-
tion and differential diagnosis (Fig. 5). Evaluation of tissue perfusion,
and contrast-enhanced MRA, would also not be possible without this
class of contrast media. Research into development of a new generation
of contrast media is ongoing for both CT and MR, with the reader re-
ferred to the specific article in this issue of Investigative Radiology fo-
cusing on intravenous contrast media.
Two software developments in MRI, slice acceleration and
sparse sampling, which will see continued attention over the next de-
cade, deserve discussion because of their potential impact long term.
For slice acceleration techniques (simultaneous multislice or multiband
imaging), the work to date is most advanced involving echo planar
DWI.54–58 Multiple slices are acquired simultaneously using blipped
controlled aliasing in parallel imaging results in higher acceleration tech-
nique with individual slices then reconstructed using a slice generalized
autocalibrating partially parallel acquisition method. An additional re-
quirement is a phased array coil with sufficient elements in the slice
encoding direction (and thus appropriate coil designs with high coil den-
sity). This approach offers a substantial decrease in image acquisition
time. Alternatively, speed can be traded for increased spatial resolution,
or with DWI increasing the number of diffusion directions sampled.
With the current implementation, in conventional 2-dimensional brain
imaging, slice acceleration factors of 2 or 3 can be used, preserving
SNR when compared with the identical nonaccelerated scan, with
little to no image artifacts (Fig. 6).59 The second technique, sparse sam-
pling, has also been referred to in the literature by the terms highly
undersampled, highly accelerated, and compressed sensing. Develop-
ment of this technique is likely to take longer than that for slice accel-
eration because of rapid ongoing evolution of the approach and the
need for fast image reconstruction. Sparse sampling is possible and
would in theory be of great value, permitting faster or higher resolution
imaging, in many instances in current clinical magnetic resonance ap-
plications. This is due to the redundancy of data that is currently sam-
pled, with image reconstruction theoretically possible using only a
small subset of this data, without a loss in diagnostic quality. Applica-
tions in CNSMR that might benefit the most, and thus be implemented
earliest, include perfusion and vessel flow. Time-of-flight, phase con-
trast, and time resolved contrast-enhanced MRA all can benefit from
sparse sampling, with initial publications primarily showing results in
volunteer studies.60–62
There is also a need in the future to look critically at the imple-
mentation in clinical imaging of the available sequences, both to
assure the choice of imaging technique that is most sensitive and to
standardize quality and time efficiency for maximum throughput
(Fig. 7). The latter is a continuing mandate by the medical insurance
system and the governments of the G7. An example of the former is
the need for better dissemination of knowledge concerning the most
sensitive scans techniques for disease detection, with a primary exam-
ple being screening and follow-up examinations for intracranial meta-
static disease.24
One important remaining topic is that of diffusion tensor imag-
ing (and next-generation diffusion MR), with future development be-
nefiting from many of the innovations and advances previously
described. The signal in DWIs is mainly determined by the microstruc-
ture of a cell and its organelles (on the scale of micrometers), in distinc-
tion to that of T1- and T2-weighted images, which is mainly determined
by molecular structures (on the scale of nanometers). Precise analyses
of diffusion MR provide intracellular and extracellular fraction changes
of water (conventional DWI), axonal/myelin-sheath direction and de-
terioration (diffusion tensor imaging),63–65 and other microstructural
information such as axonal diameter (Q-space imaging and other next-
generation diffusionmetrics). DiffusionMRI is used in quantitative anal-
yses,64,66 as well as structural connectivity analyses of the brain (Fig. 8)
and the spinal cord.67
FIGURE 7. Then and now, standardization of image tilt. As early as 1987,
inconsistent head positioning was recognized as a problem in clinical
imaging, with suggestion of standardization using a tilt in the axial plane. In
the example presented (A), improved depiction of enhancing tumor
(arrow) is noted in the low left frontal lobe with this approach.
Standardization of imaging plane is an important key today to good
clinical practice (B), with automatic image alignment (if implemented by
the technologist) as a standard part of prescan adjustments. Watershed
infarcts are presented on FLAIR images from an examination the week after
clinical presentation (left column) and at 3 months (right column).
Images in the upper row are the original axial reformatted images from the
3D data sets; the images in the lower row are reformatted to match
imaging plane for the 2 examinations. Note that by standardization of the
displayed imagingplane, the larger deepwhitematter infarct on the right
(white arrow) can now be easily identified on the follow-up examination,
and its evolution assessed, with gliosis replacing the previously identified
edema, in a slightly smaller area of involvement, with central cavitation.
Comparison of a cortical lesion in the superior parietal gyrus on the left
(black arrow), now enabled by the standardization of the presented axial
plane, reveals extensive resolution of edema with only a pinpoint area of
gliosis remaining. Reprinted with permission from Runge et al (Magn Reson
Imaging. 1987;5:421–430) and Runge (Imaging of Cerebrovascular
Disease. New York, NY: Thieme Medical Publishers [in preparation]).
FIGURE 8. Major white matter tracts depicted by diffusion tensor
tractography. Blue indicates cingulate fasciculus; light blue, uncinate
fasciculus; orange, corona radiata; green, fornix. Figure 8 can be viewed
online in color at www.investigativeradiology.com.
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In summary, advances in technology have speeded the evolution
of both CT and MR as clinical modalities, a process made possible in
part by the concurrent evolution of computers, enabling control of the
scanners, data handling, and image reconstruction as we know it today.
Much of the innovation was driven by the growing importance in clin-
ical medicine of cross-sectional imaging for disease diagnosis and treat-
ment evaluation. Imaging of the brain today occupies a central role in
medical care in regard to any question of CNS involvement or symp-
toms. This represents a marked change and critical advance from
50 years ago (1965) when diagnosis relied upon plain radiographs, pneu-
moencephalography, and cerebral (x-ray based) angiography.
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